During the past decade, Medical University of Vienna, Department of Ophthalmology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Vienna, Department of Ophthalmology" #1 sponsor was "Medical University of Vienna" with 12 trials, followed by "Hospital Hietzing" with 4 trials sponsored, "Vienna Institute for Research in Ocular Surgery" with 3 trials sponsored, "The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery" with 2 trials sponsored and "Croma-Pharma GmbH" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Vienna, Department of Ophthalmology" #1 collaborator was "Medical University of Graz" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Vienna, Department of Ophthalmology" are "Cataract" (6 trials), "Keratoconus" (4 trials), "Cataract Senile" (2 trials), "Diabetic Macular Edema" (2 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "Medical University of Vienna, Department of Ophthalmology" in a lesser frequency.

Most popular intervention types in "Medical University of Vienna, Department of Ophthalmology" are "Device" (6 trials), "Procedure" (6 trials), "Drug" (5 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biometry" (2 trials), "Auto and Subjective Refraction" (1 trials), "Bevacizumab (Avastin)" (1 trials), "Casia II (Tomey Germany, Nürnberg)" (1 trials) and "Cataract surgery with implantation of an intraocular lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Vienna, Department of Ophthalmology" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Medical University of Vienna, Department of Ophthalmology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Medical University of Vienna, Department of Ophthalmology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Vienna, Department of Ophthalmology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".